SABBY 13G EBIO 3.22.18

Company

Carisma Therapeutics Inc.

Filed

March 22, 2018

Accession Number

0001535610-18-000073

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →